| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120160 | Journal of Clinical Virology | 2015 | 6 Pages |
Abstract
Undetectable HCVAg in the early phase of TPV/Peg-IFN/RBV treatment could represent an important parameter for predicting SVR.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Anna Rosa Garbuglia, Raffaella Lionetti, Daniele Lapa, Chiara Taibi, Ubaldo Visco-Comandini, Marzia Montalbano, Gianpiero D'Offizi, Filippo Castiglione, Maria Rosaria Capobianchi, Paola Paci,